Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL13RA2 antibody

IL13RA2 Reactivity: Human ELISA, IHC, FACS Host: Mouse Monoclonal B-D13 unconjugated
Catalog No. ABIN1383686
  • Target See all IL13RA2 Antibodies
    IL13RA2 (Interleukin 13 Receptor, alpha 2 (IL13RA2))
    Reactivity
    • 55
    • 27
    • 11
    • 7
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 45
    • 8
    • 3
    Mouse
    Clonality
    • 50
    • 6
    Monoclonal
    Conjugate
    • 27
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This IL13RA2 antibody is un-conjugated
    Application
    • 48
    • 25
    • 15
    • 9
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)
    Specificity
    Recognises the IL-13 receptor a2 (IL-13 Ra2), a 44 kDa protein
    Purification
    Ion exchange chromatography
    Sterility
    0.22 μm filtered
    Immunogen
    IL-13Ra2 transfected CHO cell line,Myeloma X63/AG.8653 x Balb/c spleen cells
    Clone
    B-D13
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product IL13RA2 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
    Preservative
    Without preservative
    Storage
    4 °C
    Storage Comment
    Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
  • Kawakami, Terabe, Kioi, Berzofsky, Puri: "Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 12, Issue 15, pp. 4678-86, (2006) (PubMed).

    Kawakami, Kawakami, Puri: "Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease." in: Molecular cancer therapeutics, Vol. 3, Issue 2, pp. 137-47, (2004) (PubMed).

    Blanchard, Durual, Estienne, Bouzakri, Heim, Blin, Cuber: "IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 6, pp. 3775-83, (2004) (PubMed).

    Kawakami, Kawakami, Kasperbauer, Hinkley, Tsukuda, Strome, Puri: "Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 9, Issue 17, pp. 6381-8, (2003) (PubMed).

    Joshi, Kawakami, Leland, Puri: "Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 8, Issue 6, pp. 1948-56, (2002) (PubMed).

    Lordan, Bucchieri, Richter, Konstantinidis, Holloway, Thornber, Puddicombe, Buchanan, Wilson, Djukanović, Holgate, Davies: "Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 169, Issue 1, pp. 407-14, (2002) (PubMed).

    Kawakami, Kawakami, Puri: "IL-13 receptor-targeted cytotoxin cancer therapy leads to complete eradication of tumors with the aid of phagocytic cells in nude mice model of human cancer." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 169, Issue 12, pp. 7119-26, (2002) (PubMed).

    Joshi, Plautz, Puri: "Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas." in: Cancer research, Vol. 60, Issue 5, pp. 1168-72, (2000) (PubMed).

  • Target
    IL13RA2 (Interleukin 13 Receptor, alpha 2 (IL13RA2))
    Alternative Name
    CD213a2 (IL13RA2 Products)
    Synonyms
    il-13ra2 antibody, sb:cb602 antibody, si:dkeyp-110c7.6 antibody, CD213A2 antibody, CT19 antibody, IL-13R antibody, IL13BP antibody, CD213a2 antibody, IL-13R-alpha-2 antibody, IL13RA2 antibody, interleukin 13 receptor, alpha 2 antibody, interleukin 13 receptor subunit alpha 2 antibody, interleukin 13 receptor subunit alpha 2 S homeolog antibody, il13ra2 antibody, IL13RA2 antibody, il13ra2.S antibody, Il13ra2 antibody
    Background
    IL-13Ra2
    Molecular Weight
    74 kDa
You are here:
Support